Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | CorpVP,Global Reg.Affairs | February 13, 2020 | February 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date February 13, 2020 · Filed February 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,276 |
Ending reported balance
After 2020-02-13 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2020-02-13 · Grant · Acquired 730 · Balance 23,568 F1: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date. Row 2 · 2020-02-13 · Grant · Acquired 347 · Balance 23,915 F2: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Row 3 · 2020-02-13 · Grant · Acquired 361 · Balance 24,276 F3: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date.
F2: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date.
F3: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010229 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,276 F3 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2019 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the first anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 347 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010229 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,915 F2 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2020 at 97% of target, the second anniversary of the grant date. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 21:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010229 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,568 F1 · shares: On February 13, 2020, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2019, at least 9% and up to a maximum of 33% cumulative increase in annual revenue over the 2016 fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 34% of the shares will vest on March 13, 2020 at 150% of target, the third anniversary of the grant date. Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 66 | $56.14 | $3,705.24 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 7 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,838 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 247 | $56.14 | $13,866.58 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 6 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,904 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,025 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · derivative · entry 8 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,025 Underlying: Common Stock · 2,025 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 5 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,151 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 59 | $55.91 | $3,298.69 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 4 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,698 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 44 | $55.91 | $2,460.04 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,757 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 99 | $55.91 | $5,535.09 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,801 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 213 | $55.91 | $11,908.83 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,900 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,113 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,793 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 801 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,085 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 193 | $54.15 | $10,450.95 |
DisclosureSEC source: 0001209191-18-021807 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,284 Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 21:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 193 | $54.15 | $10,450.95 |
DisclosureSEC source: 0001209191-18-021807 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,477 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 238 | $56.14 | $13,361.32 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · nonDerivative · entry 5 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,670 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 64 | $56.14 | $3,592.96 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · nonDerivative · entry 4 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,908 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,681 | $0.00 Strike: $56.23 | $0.00 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · derivative · entry 6 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2026-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2018. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 218 | $56.23 | $12,258.14 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,972 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 57 | $56.23 | $3,205.11 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,190 Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:28 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019849 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,247 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,813 F3 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,105 F2 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011390 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,331 F1 · shares: On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 500 | $42.74 | $21,370.00 |
DisclosureSEC source: 0001209191-17-023012 · doc4.xml · nonDerivative · entry 4 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,703 Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 23:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 501 | $42.74 | $21,412.74 |
DisclosureSEC source: 0001209191-17-023012 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,203 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 206 | $42.35 | $8,724.10 |
DisclosureSEC source: 0001209191-17-023012 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,704 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 23:19 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 206 | $42.35 | $8,724.10 |
DisclosureSEC source: 0001209191-17-023012 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,910 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 68 | $43.03 | $2,926.04 |
DisclosureSEC source: 0001209191-17-020792 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,116 Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 259 | $43.03 | $11,144.77 |
DisclosureSEC source: 0001209191-17-020792 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,184 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,213 | $0.00 Strike: $43.68 | $0.00 |
DisclosureSEC source: 0001209191-17-020792 · doc4.xml · derivative · entry 4 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,213 Underlying: Common Stock · 2,213 shares Expires 2025-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2017. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020792 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,443 Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 774 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012143 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,870 F4 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2017 at 150% target, the first anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012143 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,096 F3 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 33% of the shares will vest on March 23, 2017, the second anniversary of the grant date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 21:36 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-012143 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,486 F1 · shares: On February 15, 2017, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2016, at least a 3% increase in annual revenue over the prior fiscal year, under the March 24, 2014 Performance Stock Award. Accordingly, 34% of the shares will vest on March 24, 2017, the third anniversary of the grant date. F2 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date and one additional unit of unvested performance based restricted stock ("PSU") for each PSU owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.